TechMARK movers: Ark valued at discount to NAV

9th Mar 2011 14:59

Drug developer Ark Therapeutics has fallen after announcing a £10.7m cash outflow from operations in 2010. Net cash has fallen to £7.07m, from £14.1m in June, which is £1m less than the market value of Ark. The cash does not include the money received for the sale of Ark's wound care business, which brought in a further £770,000. There will have been a cash outflow since December, though. Ark's net asset value, excluding intangible assets, is just under £17m. Industrial ink jet and laser printing equipment provider Domino Printing Sciences has gone ex-dividend. The dividend is 10.14p a share but the share price decline is three times that figure. Spirent Communications has also gone ex-dividend today but the share price has declined by around four times the 0.86p a share dividend. Drug developer turned cash shell Antisoma making progress with its restructuring. There are 10 employees left and this number will fall further next month. This will conserve cash. FTSE TechMARK - Risers Skyepharma (SKP) 41.00p +12.33%Vectura Group (VEC) 67.25p +7.17%Antisoma (ASM) 2.75p +5.77%Chemring Group (CHG) 3,484.00p +3.88%Autonomy Corporation (AU.) 1,698.00p +2.78%Corin Group (CRG) 47.00p +2.73%Wolfson Microelectronics (WLF) 271.75p +1.87%Innovation Group (TIG) 16.25p +1.56%Axis-Shield (ASD) 314.75p +1.53%Phytopharm (PYM) 7.70p +0.98%FTSE TechMARK - Fallers AEA Technology Group (AAT) 4.25p -10.53%Ark Therapeutics Group (AKT) 3.85p -7.23%Domino Printing Sciences (DNO) 670.00p -4.69%Spirent Communications (SPT) 146.20p -3.37%BATM Advanced Communications Ltd. (BVC) 21.00p -3.45%XP Power Ltd. (DI) (XPP) 1,860.00p -2.62%ARM Holdings (ARM) 577.00p -2.12%Sepura (SEPU) 46.25p -1.60%BT Group (BT.A) 188.10p -1.57%Anite (AIE) 64.50p -0.77%